| Literature DB >> 29138942 |
Jonny Nordström1,2, Tanja Kero3,4, Hendrik Johannes Harms5, Charles Widström3,6, Frank A Flachskampf7, Jens Sörensen3,4, Mark Lubberink3,6.
Abstract
BACKGROUND: Quantitative measurement of myocardial blood flow (MBF) is of increasing interest in the clinical assessment of patients with suspected coronary artery disease (CAD). 15O-water positron emission tomography (PET) is considered the gold standard for non-invasive MBF measurements. However, calculation of left ventricular (LV) volumes and ejection fraction (EF) is not possible from standard 15O-water uptake images. The purpose of the present work was to investigate the possibility of calculating LV volumes and LVEF from cardiac-gated parametric blood volume (V B) 15O-water images and from first pass (FP) images. Sixteen patients with mitral or aortic regurgitation underwent an eight-gate dynamic cardiac-gated 15O-water PET/CT scan and cardiac MRI. V B and FP images were generated for each gate. Calculations of end-systolic volume (ESV), end-diastolic volume (EDV), stroke volume (SV) and LVEF were performed with automatic segmentation of V B and FP images, using commercially available software. LV volumes and LVEF were calculated with surface-, count-, and volume-based methods, and the results were compared with gold standard MRI.Entities:
Year: 2017 PMID: 29138942 PMCID: PMC5686036 DOI: 10.1186/s40658-017-0195-2
Source DB: PubMed Journal: EJNMMI Phys ISSN: 2197-7364
Patient characteristics including outliers
| Age (years) | 58 ± 13 |
| Gender (female/male) | 4/12 |
| Height (cm) | 176 ± 8 |
| Weight (kg) | 76 ± 10 |
| BSA (m2) | 1.9 ± 0.15 |
| Heart rate (mean/range) | 62/47–105 |
| LVESV (mL/range) | 90 ± 29/44–148 |
| LVEDV (mL/range) | 244 ± 65/153–412 |
| LVSV (mL/range) | 154 ± 42/109–277 |
| LVEF (%/range) | 63 ± 6/53–75 |
| Diabetes ( | 0 |
| NYHA class 1 ( | 15 |
| NYHA class 2 ( | 1 |
| Mitral insufficiency ( | 13 |
| Aortic insufficiency ( | 3 |
| CAD ( | 0 |
| History of MI ( | 0 |
| Hypertension ( | 7 |
| History of AF ( | 0 |
| Treatment | |
| ASA ( | 1 |
| ACE/ARB ( | 8 |
| CCB ( | 1 |
| Diuretics ( | 1 |
| Beta blockers ( | 3 |
| History of PCI ( | 0 |
Fig. 1End-diastolic (top row) and end-systolic (bottom row) short-axis parametric 15O-water blood volume (V B), transmural blood flow (MBFt) and perfusable tissue fraction (PTF) images, as well as MRI images of a typical patient. Colour scales for end-diastolic and end-systolic images are identical
Fig. 2End-diastolic (left) and end-systolic (right) fusion between parametric 15O-water blood volume (V B) and MRI images
Including outliers, correlation between PET and MRI for surface- (s), count- (c) and volume-based (v) methods. The count-based method does not provide ESV and EDV values
| Slope, | Intercept, |
|
| |
| ESVs | 0.93 | 12.7 | 0.73 | 0.001 |
| EDVs | 0.60 | 59.3 | 0.66 | 0.006 |
| SVs | 0.37 | 53.2 | 0.58 | 0.017 |
| LVEFs | 0.66 | 12.9 | 0.58 | 0.018 |
| ESVv | 1.00 | − 3.5 | 0.79 | < 0.001 |
| EDVv | 0.70 | 80.4 | 0.66 | 0.006 |
| SVv | 0.53 | 82.3 | 0.54 | 0.030 |
| LVEFv | 0.88 | 10.6 | 0.65 | 0.006 |
| LVEFc | 0.83 | 22.1 | 0.62 | 0.011 |
| Slope, FP | Intercept, FP |
|
| |
| ESVs | 1.20 | − 8.3 | 0.90 | < 0.001 |
| EDVs | 0.79 | 1.10 | 0.87 | < 0.001 |
| SVs | 0.50 | 16.30 | 0.74 | < 0.001 |
| LVEFs | 0.77 | 0.08 | 0.63 | 0.008 |
| ESVv | 1.32 | − 19.50 | 0.87 | < 0.001 |
| EDVv | 0.91 | 12.56 | 0.87 | < 0.001 |
| SVv | 0.70 | 28.54 | 0.73 | < 0.001 |
| LVEFv | 1.03 | − 6.83 | 0.64 | 0.006 |
| LVEFc | 1.12 | − 1.83 | 0.66 | 0.005 |
Excluding outliers, correlation between PET and MRI for surface- (s), count- (c), and volume-based (v) methods. The count-based method does not provide ESV and EDV values
| Slope, | Intercept, |
|
| |
| ESVs | 1.08 | 10.3 | 0.88 | < 0.001 |
| EDVs | 0.96 | − 4.2 | 0.85 | 0.001 |
| SVs | 0.68 | 16.2 | 0.73 | 0.007 |
| LVEFs | 0.77 | 4.6 | 0.71 | 0.009 |
| ESVv | 1.15 | − 6.2 | 0.89 | < 0.001 |
| EDVv | 1.1 | 10 | 0.85 | < 0.001 |
| SVv | 1.04 | 19.9 | 0.74 | 0.006 |
| LVEFv | 0.93 | 6.5 | 0.72 | 0.008 |
| LVEFc | 0.88 | 17.5 | 0.70 | 0.01 |
| Slope, FP | Intercept, FP |
|
| |
| ESVs | 1.24 | − 6.2 | 0.95 | < 0.001 |
| EDVs | 0.92 | − 20.8 | 0.88 | < 0.001 |
| SVs | 0.50 | 20.0 | 0.56 | 0.022 |
| LVEFs | 0.83 | 3.6 | 0.68 | 0.003 |
| ESVv | 1.40 | − 21.6 | 0.89 | < 0.001 |
| EDVv | 1.07 | − 13.2 | 0.87 | < 0.001 |
| SVv | 0.75 | 28.1 | 0.57 | 0.018 |
| LVEFv | 1.07 | − 8.6 | 0.65 | 0.005 |
| LVEFc | 0.91 | 11.6 | 0.60 | 0.012 |
Fig. 3Correlation between 15O-water PET volume-based method and MRI ESV (a), EDV (b), SV (c) and LVEF (d). Circles (red) are values from V B images, and squares (blue) are values from FP images. Solid lines are linear regression lines, and dashed lines are lines of identity. Outliers were removed
Fig. 4Bland Altman plots between 15O-water PET volume-based method and MRI ESV (a), EDV (b), SV (c) and LVEF (d). Circles (red) are values from V B images, and squares (blue) are values from FP images. Solid lines are the mean difference, and dashed lines are the limits of agreement. Outliers were removed
Including outliers, average LV volumes and LVEF calculated from PET using surface- (s), count- (c), and volume-based (v) methods compared with average values from MRI
| PET, | MRI | Relative difference (%), |
| |
| ESVs, mL | 96 ± 36 | 90 ± 29 | 8.5 ± 29.8 | 0.347 |
| EDVs, mL | 206 ± 60 | 243 ± 65 | − 14.4 ± 18.4 | 0.012 |
| SVs, mL | 110 ± 27 | 154 ± 42 | − 26.7 ± 15.1 | < 0.001 |
| LVEFs, % | 55 ± 6 | 63 ± 6 | − 13.8 ± 8.7 | < 0.001 |
| ESVv, mL | 87 ± 36 | 90 ± 29 | − 2.7 ± 26.8 | 0.622 |
| EDVv, mL | 250 ± 69 | 244 ± 65 | 4.0 ± 21.6 | 0.652 |
| SVv, mL | 163 ± 41 | 154 ± 42 | 8.1 ± 23.5 | 0.372 |
| LVEFv, % | 66 ± 8 | 63 ± 6 | 4.2 ± 9.4 | 0.10 |
| LVEFc, % | 75 ± 8 | 63 ± 6 | 17.8 ± 10 | < 0.001 |
| PET, FP | MRI | Relative difference (%), FP |
| |
| ESVs, mL | 100 ± 38 | 90 ± 29 | 11.2 ± 19.5 | 0.041 |
| EDVs, mL | 192 ± 59 | 243 ± 65 | − 21.2 ± 12.7 | < 0.001 |
| SVs, mL | 93 ± 28 | 154 ± 42 | − 39.2 ± 13.6 | < 0.001 |
| LVEFs, % | 49 ± 7 | 63 ± 6 | − 23.0 ± 8.9 | < 0.001 |
| ESVv, mL | 99 ± 43 | 90 ± 29 | 9.2 ± 22.5 | 0.126 |
| EDVv, mL | 235 ± 68 | 244 ± 65 | − 3.5 ± 14.7 | 0.320 |
| SVv, mL | 136 ± 40 | 154 ± 42 | − 10.9 ± 19.8 | 0.031 |
| LVEFv, % | 59 ± 9 | 63 ± 6 | − 7.8 ± 11.4 | 0.017 |
| LVEFc, % | 69 ± 10 | 63 ± 6 | 8.6 ± 11.5 | 0.008 |
Excluding outliers, average LV volumes and LVEF calculated from PET using surface- (s), count- (c) and volume-based (v) methods compared with average values from MRI
| PET, | MRI | Relative difference (%), |
| |
| ESVs, mL | 103 ± 34 | 86 ± 28 | 21.3 ± 20.6 | 0.004 |
| EDVs, mL | 219 ± 53 | 232 ± 47 | − 5.8 ± 11.3 | 0.137 |
| SVs, mL | 116 ± 24 | 146 ± 26 | − 20.5 ± 11.6 | < 0.001 |
| LVEFs, % | 54 ± 7 | 64 ± 2 | − 15.5 ± 7.6 | < 0.001 |
| ESVv, mL | 92 ± 36 | 86 ± 28 | 7.6 ± 20.6 | 0.221 |
| EDVv, mL | 264 ± 61 | 232 ± 47 | 14.1 ± 13.6 | 0.005 |
| SVv, mL | 172 ± 37 | 146 ± 26 | 17.9 ± 17.6 | 0.004 |
| LVEFv, % | 66 ± 8 | 64 ± 2 | 3.3 ± 9.0 | 0.203 |
| LVEFc, % | 74 ± 8 | 64 ± 2 | 15.8 ± 9.1 | < 0.001 |
| PET, FP | MRI | Relative difference (%), FP |
| |
| ESVs, mL | 100 ± 36 | 86 ± 28 | 16.9 ± 13.8 | 0.003 |
| EDVs, mL | 193 ± 49 | 232 ± 47 | − 16.9 ± 10.4 | < 0.001 |
| SVs, mL | 94 ± 23 | 146 ± 26 | − 35.7 ± 13.8 | < 0.001 |
| LVEFs, % | 49 ± 8 | 64 ± 2 | − 23.0 ± 9.0 | < 0.001 |
| ESVv, mL | 98 ± 43 | 86 ± 28 | 13.6 ± 21.2 | 0.076 |
| EDVv, mL | 236 ± 56 | 232 ± 47 | 1.5 ± 12.1 | 0.652 |
| SVv, mL | 137 ± 34 | 146 ± 26 | − 5.5 ± 19.9 | 0.307 |
| LVEFv, % | 59 ± 10 | 64 ± 2 | − 7.2 ± 12.5 | 0.074 |
| LVEFc, % | 70 ± 9 | 64 ± 2 | 9.8 ± 11.9 | 0.015 |
Intraclass correlation coefficient (ICC) for inter-operator repeatability including and excluding outliers (p < 0.001 for all)
| ICC including outliers | ICC excluding outliers | |
|---|---|---|
| ESVs | 0.97 | 0.98 |
| EDVs | 0.99 | 0.99 |
| SVs | 0.95 | 0.94 |
| LVEFs | 0.85 | 0.89 |
| ESVv | 0.94 | 0.94 |
| EDVv | 0.99 | 0.99 |
| SVv | 0.93 | 0.92 |
| LVEFv | 0.78 | 0.86 |
| LVEFc | 0.80 | 0.89 |